We derive actionable insights from millions of scientific articles, patents, public data banks covering clinical, genomic, proteomic and transcriptomic data as well as clinical trial publications.
our mission
Change paradigm in pharma
Drug development using AI supported predictive analysis for synergistic drug combinations and multi API newly formulated drugs, provide justification to expand the use of existing drugs into more indications and diseases.
It also helps to expand indication and reposition drugs. Further to this, there are for many rare and orphan disease no drugs available. Our approach can help to change this.
Our platform contains data from
1000+
signaling pathways associated with drugs
11,000+
biomarkers linked to drugs
1M+
unique relationships between drug-biomarker-disease-signaling pathways
14,000+
Investigational, approved or withdrawn drugs
7000+
disease conditions that can be treated using drugs
Our platform needs only minutes to gather the actionable insights from millions of documents and publications
Our Services
Customer Segments
Biopharmaceutical Industry
Lifescience and Biotech companies who seek to derive key insights from vast amounts of data to make smart project-related decisions.
Academic Institutions
Research labs who need to organize domain-specific scientific data and stay upto-date on the research trends in the concerned scientific domain.
Venture Capitalist & Consulting firms
Investors who need specific market trends and scientific intelligence to evaluate prospective deals.